Vancomycin Dosing and Monitoring in the Treatment of Cystic Fibrosis: Results of a National Practice Survey

OBJECTIVES: Vancomycin is commonly used in patients with cystic fibrosis (CF) to treat acute pulmonary exacerbations, but few guidelines exist to help dose and monitor patients. The objective of this study was to assess vancomycin use and monitoring strategies at Cystic Fibrosis Foundation (CFF)–acc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Pediatr Pharmacol Ther
Main Authors: Pettit, Rebecca S., Peters, Stacy J., McDade, Erin J., Kreilein, Kaci, Patel, Radha, Epps, Kevin, Kittell, Frederick, Duval, Mariela A., Zobell, Jeffery T.
Format: Artigo
Jezik:Inglês
Izdano: Pediatric Pharmacy Advocacy Group 2017
Teme:
Clinical Investigations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736252/
https://ncbi.nlm.nih.gov/pubmed/29290740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-22.6.406
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki